Important options available — from start to finish — for translating proteomics results to clinical chemistry

No abstract is available for this paper.

• Publication year

  2015

• Venue

  PROTEOMICS - Clinical Applications

• Publication date

  2015-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/prca.201400137PMID 25472910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A draft map of the human proteome

  2014cited by this paper
• Mass-spectrometry-based draft of the human proteome

  2014cited by this paper
• From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometry.

  2014cited by this paper
• Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.

  2014cited by this paper
• Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry.

  2014cited by this paper
• Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ *

  2014cited by this paper
• Deciphering the ovarian cancer ascites fluid peptidome

  2014cited by this paper
• Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin.

  2014cited by this paper
• Detection and quantification of plasma amyloid-β by selected reaction monitoring mass spectrometry.

  2014cited by this paper
• Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.

  2014cited by this paper
• Validation of a blood protein signature for non-small cell lung cancer

  2014cited by this paper
• Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

  2014cited by this paper
• Deep Proteomic Evaluation of Primary and Cell Line Motoneuron Disease Models Delineates Major Differences in Neuronal Characteristics*

  2014cited by this paper
• Panorama: A Targeted Proteomics Knowledge Base

  2014cited by this paper
• Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics

  2014cited by this paper
• Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker.

  2013cited by this paper
• Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  2013cited by this paper
• Quantitative Assessment of In-solution Digestion Efficiency Identifies Optimal Protocols for Unbiased Protein Analysis*

  2013cited by this paper
• Label-free quantification in clinical proteomics.

  2013cited by this paper
• Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.

  2013cited by this paper
• Cleaning up the masses: Exclusion lists to reduce contamination with HPLC-MS/MS

  2013cited by this paper
• Multi-Resolution-Test for Consistent phenotype Discrimination and biomarker Discovery in Translational Bioinformatics

  2013cited by this paper
• Pre-analytical stability of the plasma proteomes based on the storage temperature

  2013cited by this paper
• Design, Implementation and Multisite Evaluation of a System Suitability Protocol for the Quantitative Assessment of Instrument Performance in Liquid Chromatography-Multiple Reaction Monitoring-MS (LC-MRM-MS)*

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

  2013cited by this paper
• Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

  2013cited by this paper
• Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.

  2013cited by this paper
• Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.

  2013cited by this paper
• A Selected Reaction Monitoring (SRM)-Based Method for Absolute Quantification of Aβ38, Aβ40, and Aβ42 in Cerebrospinal Fluid of Alzheimer's Disease Patients and Healthy Controls

  2013cited by this paper
• Genome-scale Proteome Quantification by DEEP SEQ Mass Spectrometry

  2013cited by this paper
• Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.

  2013cited by this paper
• Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

  2013cited by this paper
• A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers

  2013cited by this paper
• Glycosylated Fibronectin as a First-Trimester Biomarker for Prediction of Gestational Diabetes

  2013cited by this paper
• A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.

  2012cited by this paper
• Systems-Based Approaches to Cardiovascular Biomarker Discovery

  2012cited by this paper
• Statistical methods for quantitative mass spectrometry proteomic experiments with labeling

  2012cited by this paper
• The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines

  2012cited by this paper
• Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics

  2012influential reference
• Multiple Reaction Monitoring to Identify Site-Specific Troponin I Phosphorylated Residues in the Failing Human Heart

  2012cited by this paper
• A Novel Mass Spectrometry–Based Assay for the Accurate Measurement of Thyroglobulin From Patient Samples Containing Antithyroglobulin Autoantibodies

  2012cited by this paper
• Accurate multiplexed proteomics at the MS2 level using the complement reporter ion cluster.

  2012cited by this paper
• Global Stability of Plasma Proteomes for Mass Spectrometry-Based Analyses*

  2012cited by this paper
• Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum

  2012cited by this paper
• Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer*

  2012cited by this paper
• Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses.

  2012cited by this paper
• A Novel Method for the Simultaneous Enrichment, Identification, and Quantification of Phosphopeptides and Sialylated Glycopeptides Applied to a Temporal Profile of Mouse Brain Development*

  2012cited by this paper
• Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring?

  2012cited by this paper
• Using lectins to harvest the plasma/serum glycoproteome

  2012cited by this paper
• Sequential Multiplexed Analyte Quantification Using Peptide Immunoaffinity Enrichment Coupled to Mass Spectrometry*

  2011cited by this paper
• MS3 eliminates ratio distortion in isobaric labeling-based multiplexed quantitative proteomics

  2011cited by this paper
• Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes.

  2011cited by this paper
• ms3 eliminates ratio distortion in isobaric multiplexed quantitative

  2011cited by this paper
• A case study on the comparison of different software tools for automated quantification of peptides.

  2011cited by this paper
• Sample Preparation in Biological Mass Spectrometry

  2011cited by this paper
• Preanalytical Variables for Plasma and Serum Proteome Analyses

  2011cited by this paper
• A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease

  2011cited by this paper
• LC-MS/MS in the Clinical Laboratory - Where to From Here?

  2011cited by this paper
• Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants.

  2010cited by this paper
• Selective enrichment of sialic acid–containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry

  2010cited by this paper
• High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins

  2010cited by this paper
• Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent

  2010cited by this paper
• Microarrays in the clinic

  2010cited by this paper
• Increased Selectivity, Analytical Precision, and Throughput in Targeted Proteomics

  2010cited by this paper
• Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.

  2010cited by this paper
• Depletion of abundant plasma proteins and limitations of plasma proteomics.

  2010cited by this paper
• Super-SILAC mix for quantitative proteomics of human tumor tissue

  2010cited by this paper
• Macrophage-Mediated Proteolytic Remodeling of the Extracellular Matrix in Atherosclerosis Results in Neoepitopes: A Potential New Class of Biochemical Markers

  2010cited by this paper
• Comprehensive maternal serum proteomic profiles of preclinical and clinical preeclampsia.

  2010cited by this paper
• The cost of large numbers of hypothesis tests on power, effect size and sample size

  2010influential reference
• Finding Biomarker Signatures in Pooled Sample Designs: A Simulation Framework for Methodological Comparisons

  2010cited by this paper
• Role of spectral counting in quantitative proteomics

  2010cited by this paper
• Sample size and statistical power considerations in high-dimensionality data settings: a comparative study of classification algorithms

  2010cited by this paper
• The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers

  2010cited by this paper
• Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

  2009cited by this paper
• An Enhanced Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture*S

  2009influential reference
• Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.

  2009cited by this paper
• The Elements of Statistical Learning: Data Mining, Inference, and Prediction, 2nd Edition

  2009cited by this paper
• Methods for Assessing Improvement in Specificity When a Biomarker is Combined With a Standard Screening Test

  2009cited by this paper
• MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

  2008cited by this paper
• Frontiers in glycomics: Bioinformatics and biomarkers in disease An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11–13, 2006)

  2008cited by this paper
• Identifying differences in protein expression levels by spectral counting and feature selection.

  2008cited by this paper
• Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.

  2008cited by this paper
• Pooling serum samples may lead to loss of potential biomarkers in SELDI-ToF MS proteomic profiling

  2008cited by this paper
• The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species.

  2008cited by this paper
• Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

  2008cited by this paper
• SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.

  2008cited by this paper
• Data analysis of assorted serum peptidome profiles

  2007cited by this paper
• Exploring the Sialiome Using Titanium Dioxide Chromatography and Mass Spectrometry *S

  2007cited by this paper
• Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

  2007cited by this paper
• p53 in health and disease

  2007cited by this paper
• N-Glycosylation Site Occupancy in Serum Glycoproteins Using Multiple Reaction Monitoring Liquid Chromatography-Mass Spectrometry*

  2007cited by this paper
• Sialyltransferase STX (ST8SiaII): A novel molecular marker of metastatic neuroblastoma

  2006cited by this paper
• Microarray data analysis: from disarray to consolidation and consensus

  2006cited by this paper
• Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column

  2006cited by this paper
• CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

  2006cited by this paper
• Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins*

  2006influential reference
• Sample handling for mass spectrometric proteomic investigations of human sera.

  2005cited by this paper
• Who should operate on patients with ovarian cancer? An evidence-based review.

  2005cited by this paper

• The Use of Antibody Arrays in the Discovery of New Plasma Biomarkers for Endometriosis

  2020cites this paper
• Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer

  2018cites this paper
• Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT

  2018cites this paper
• Biomarkers of Renal Cancer

  2017cites this paper
• A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus

  2017cites this paper
• Systems Biology: Methods and Applications

  2017cites this paper
• Clinical applications of MS‐based protein quantification

  2016cites this paper
• First-trimester multimarker prediction of gestational diabetes mellitus using targeted mass spectrometry

  2016cites this paper
• Novel Chemical Tools and Methods for Quantitative Mass Spectrometry-Based Proteomics

  2015cites this paper